The Biden administration has put forth a proposal to revise various Medicare and Medicaid regulations and include obesity medications as part of their coverage. This coverage could rack up $25 billion in Medicare spending and $11 billion in Medicaid, with the federal government footing that bill. Sanger-Katz M. Obesity drugs would be covered by Medicare and Medicaid under Biden proposal. Medicare and Medicaid Programs: Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly. Montero A, Sparks G, Presiado M, Hamel L. KFF Health Tracking Poll May 2024: the public’s use and views of GLP-1 drugs.

Source: New York Times November 26, 2024 21:21 UTC